Organon To Report First Quarter Results and Host Conference Call on May 5, 2022Business Wire • 04/21/22
Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)Seeking Alpha • 03/09/22
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/17/22
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021Business Wire • 02/17/22
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People's Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in VietnamBusiness Wire • 02/16/22
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022Business Wire • 02/01/22
Healthy Dividends: Organon's Dividend Bolsters The Long-Term Investment In A Fresh TickerSeeking Alpha • 01/22/22
Organon & Co. (OGN) CEO Kevin Ali on JPMorgan 40th Annual Healthcare Conference (Transcript)Seeking Alpha • 01/11/22
FDA Accepts Samsung Bioepis' and Organon's sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar CandidateBusiness Wire • 01/05/22
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual ConferenceBusiness Wire • 12/20/21
Organon's acquisition of Karolinska Development's portfolio company Forendo Pharma has been successfully completedGlobeNewsWire • 12/13/21